MAGEA3 Antibodies

Target Information

Proposed to enhance ubiquitin ligase activity of RING-type zinc finger-containing E3 ubiquitin-protein ligases. May enhance ubiquitin ligase activity of TRIM28 and stimulate p53/TP53 ubiquitination by TRIM28. Proposed to act through recruitment and/or stabilization of the Ubl-conjugating enzyme (E2) at the E3:substrate complex. May play a role in embryonal development and tumor transformation or aspects of tumor progression. In vitro promotes cell viability in melanoma cell lines. Antigen recognized on a melanoma by autologous cytolytic T-lymphocytes. Expressed in many tumors of several types, such as melanoma, head and neck squamous cell carcinoma, lung carcinoma and breast carcinoma, but not in normal tissues except for testes and placenta. Never expressed in kidney tumors, Leukemias and lymphomas. Note: This description may include information from UniProtKB.

Alternate Names

Antigen MZ2-D; Cancer/testis antigen 1.3; cancer/testis antigen family 1, member 3; CT1.3; CT1.6; HIP8; HYPD; MAGA3; MAGE family member A3; MAGE-3 antigen; MAGE3; MAGEA3; MAGEA6; melanoma antigen family A, 3; melanoma antigen family A3; Melanoma-associated antigen 3; MGC14613